Parkway Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
402,635
+4,784
+1% +$121K 1.17% 23
2026
Q1
$10.1M Buy
397,851
+34,761
+10% +$887K 1.28% 22
2025
Q4
$9.27M Buy
+363,090
New +$9.29M 1.24% 18

Other funds holding IBDX

Parkway Wealth Management's IBDX Position: Q2 2026 in Review

Parkway Wealth Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.2% in Q2 2026, buying an estimated $121K and bringing the position to 402,635 shares worth $10.1M. The position accounts for 1.17% of the portfolio, ranked #23.

Parkway Wealth Management first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Parkway Wealth Management held 402,635 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $10.1M as of Q2 2026.
  • Parkway Wealth Management bought 4,784 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $121K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.17% of Parkway Wealth Management's portfolio in Q2 2026, its #23 holding.
  • Parkway Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Parkway Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.